KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exelixis (EXEL) Cash & Equivalents (2016 - 2026)

Exelixis has reported Cash & Equivalents over the past 17 years, most recently at $482.5 million for Q1 2026.

  • Quarterly results put Cash & Equivalents at $482.5 million for Q1 2026, up 121.96% from a year ago — trailing twelve months through Jan 2026 was $482.5 million (up 121.96% YoY), and the annual figure for FY2026 was $482.5 million, up 121.96%.
  • Cash & Equivalents for Q1 2026 was $482.5 million at Exelixis, up from $376.3 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for EXEL hit a ceiling of $723.3 million in Q2 2022 and a floor of $164.4 million in Q3 2025.
  • Median Cash & Equivalents over the past 5 years was $386.6 million (2023), compared with a mean of $395.8 million.
  • Biggest five-year swings in Cash & Equivalents: plummeted 57.27% in 2024 and later soared 121.96% in 2026.
  • Exelixis' Cash & Equivalents stood at $501.2 million in 2022, then crashed by 47.53% to $263.0 million in 2023, then dropped by 1.77% to $258.3 million in 2024, then soared by 45.66% to $376.3 million in 2025, then increased by 28.22% to $482.5 million in 2026.
  • The last three reported values for Cash & Equivalents were $482.5 million (Q1 2026), $376.3 million (Q4 2025), and $164.4 million (Q3 2025) per Business Quant data.